A report on Malaria, Chloroquine, Antimalarial medication and Plasmodium vivax

Malaria parasite connecting to a red blood cell

The life cycle of malaria parasites. Sporozoites are introduced by a mosquito bite. They migrate to the liver, where they multiply into thousands of merozoites. The merozoites infect red blood cells and replicate, infecting more and more red blood cells. Some parasites form gametocytes, which are taken up by a mosquito, continuing the life cycle.

Hemozoin formation in P. falciparum: many antimalarials are strong inhibitors of hemozoin crystal growth.

Micrograph of a placenta from a stillbirth due to maternal malaria. H&E stain. Red blood cells are anuclear; blue/black staining in bright red structures (red blood cells) indicate foreign nuclei from the parasites.

Electron micrograph of a Plasmodium falciparum-infected red blood cell (center), illustrating adhesion protein "knobs"

The blood film is the gold standard for malaria diagnosis.

Ring-forms and gametocytes of Plasmodium falciparum in human blood

An Anopheles stephensi mosquito shortly after obtaining blood from a human (the droplet of blood is expelled as a surplus). This mosquito is a vector of malaria, and mosquito control is an effective way of reducing its incidence.

Man spraying kerosene oil in standing water, Panama Canal Zone, 1912

Walls where indoor residual spraying of DDT has been applied. The mosquitoes remain on the wall until they fall down dead on the floor.

An advertisement for quinine as a malaria treatment from 1927.

Deaths due to malaria per million persons in 2012

Past and current malaria prevalence in 2009

Ancient malaria oocysts preserved in Dominican amber

British doctor Ronald Ross received the Nobel Prize for Physiology or Medicine in 1902 for his work on malaria.

Chinese medical researcher Tu Youyou received the Nobel Prize for Physiology or Medicine in 2015 for her work on the antimalarial drug artemisinin.

Artemisia annua, source of the antimalarial drug artemisinin

U.S. Marines with malaria in a field hospital on Guadalcanal, October 1942

Members of the Malaria Commission of the League of Nations collecting larvae on the Danube delta, 1929

1962 Pakistani postage stamp promoting malaria eradication program

Disability-adjusted life year for malaria per 100,000 inhabitants in 2004
no data
<10
0–100
100–500
500–1000
1000–1500
1500–2000
2000–2500
2500–2750
2750–3000
3000–3250
3250–3500
≥3500

Chloroquine is a medication primarily used to prevent and treat malaria in areas where malaria remains sensitive to its effects.

- Chloroquine

Antimalarial medications or simply antimalarials are a type of antiparasitic chemical agent, often naturally derived, that can be used to treat or to prevent malaria, in the latter case, most often aiming at two susceptible target groups, young children and pregnant women.

- Antimalarial medication

This parasite is the most frequent and widely distributed cause of recurring malaria.

- Plasmodium vivax

As well, despite very positive outcomes from many modern treatments, serious side effects can impact some individuals taking standard doses (e.g., retinopathy with chloroquine, acute haemolytic anaemia with tafenoquine).

- Antimalarial medication

Most deaths are caused by P. falciparum, whereas P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.

- Malaria

Quinine is an alkaloid that acts as a blood schizonticidal and weak gametocide against Plasmodium vivax and Plasmodium malariae.

- Antimalarial medication

]]Chloroquine has been used in the treatment and prevention of malaria from Plasmodium vivax, ''[[Plasmodium ovale|P.

- Chloroquine

The recommended treatment for malaria is a combination of antimalarial medications that includes artemisinin.

- Malaria

In areas where resistance is present, other antimalarials, such as mefloquine or atovaquone, may be used instead.

- Chloroquine

Resistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.

- Malaria

Chloroquine remains the treatment of choice for vivax malaria, except in Indonesia's Irian Jaya (Western New Guinea) region and the geographically contiguous Papua New Guinea, where chloroquine resistance is common (up to 20% resistance).

- Plasmodium vivax

Where an artemisinin-based combination therapy has been adopted as the first-line treatment for P. falciparum malaria, it may also be used for P. vivax malaria in combination with primaquine for radical cure.

- Plasmodium vivax

3 related topics with Alpha

Plasmodium falciparum

1 links

Laveran's drawing of various stages of P. falciparum as seen on fresh blood (1880).

Blood smear from a P. falciparum culture (K1 strain - asexual forms) - several red blood cells have ring stages inside them. Close to the center is a schizont and on the left a trophozoite.

Ring forms in red blood cells (Giemsa stain)

Plasmodium falciparum is a unicellular protozoan parasite of humans, and the deadliest species of Plasmodium that causes malaria in humans.

In 1900, the Italian zoologist Giovanni Battista Grassi categorized Plasmodium species based on the timing of fever in the patient; malignant tertian malaria was caused by Laverania malariae (now P. falciparum), benign tertian malaria by Haemamoeba vivax (now P. vivax), and quartan malaria by Haemamoeba malariae (now P. malariae).

In the late 1930s, the Germans developed chloroquine, which went into use in the North African campaigns.

According to WHO guidelines 2010, artemisinin-based combination therapies (ACTs) are the recommended first-line antimalarial treatments for uncomplicated malaria caused by P. falciparum.

Plasmodium

1 links

Genus of unicellular eukaryotes that are obligate parasites of vertebrates and insects.

Plasmodium is a eukaryote but with unusual features.

Life cycle of a species that infects humans

Ring forms of Plasmodium inside human red blood cells (Giemsa stain)

Sporozoites, one of several different forms of the parasite, from a mosquito

Oldest mosquito fossil with Plasmodium dominicana, 15-20 million year old

Many birds, from raptors to passerines like the red-whiskered bulbul (Pycnonotus jocosus), can carry malaria.

A clinic for treating human malaria in Tanzania

Over 3000 species of lizard, including the Carolina anole (Anolis carolinensis), carry some 90 kinds of malaria.

The mosquito Anopheles stephensi is among the blood-feeding insects that can be infected by a species of Plasmodium.

The ensuing destruction of host red blood cells can result in malaria.

Over the course of the 20th century, many other species were discovered in various hosts and classified, including five species that regularly infect humans: P. vivax, P. falciparum, P. malariae, P. ovale, and P. knowlesi.

A number of drugs have been developed to treat Plasmodium infection; however, the parasites have evolved resistance to each drug developed.

Resistance to quinine spurred the development of a broad array of antimalarial medications through the 20th century including chloroquine, proguanil, atovaquone, sulfadoxine/pyrimethamine, mefloquine, and artemisinin.

Mefloquine

0 links

Mefloquine, sold under the brand name Lariam among others, is a medication used to prevent or treat malaria.

Mefloquine is used as a treatment for chloroquine-sensitive or resistant Plasmodium falciparum malaria, and is deemed a reasonable alternative for uncomplicated chloroquine-resistant Plasmodium vivax malaria.

It is not recommended for severe malaria infections, particularly infections from P. falciparum, which should be treated with intravenous antimalarials.